Anastomosis Devices Market Trends and Demand Forecast 2025-2033

6 views
Skip to first unread message

Rohit Pujari

unread,
Dec 26, 2024, 3:08:11 AM12/26/24
to Market Research guide

IMARC Group’s report titled “Anastomosis Devices Market Report by Type (Surgical Staplers, Surgical Sutures, Automated Suturing Devices, Surgical Sealants and Adhesives), Application (Gastrointestinal Surgeries, Cardiovascular and Thoracic Surgeries, and Others), End User (Hospitals, Ambulatory Surgical Centers and Clinics, and Others), and Region 2025-2033”, The global anastomosis devices market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033.

Grab a sample PDF of this report: https://www.imarcgroup.com/anastomosis-devices-market/requestsample

Factors Affecting the Growth of the Anastomosis Devices Industry:

  • Increasing Surgical Procedures and Demand for Minimally Invasive Techniques:

The market for anastomosis devices is growing because of more surgeries happening worldwide and the increasing use of minimally invasive techniques. In 2024, as healthcare advances, doctors are doing more surgeries that cause less pain and require shorter recovery times. These surgeries, like laparoscopic surgery, are becoming more popular because they help patients recover faster and spend less time in the hospital. To make these procedures successful, specialized anastomosis devices are needed to connect tissues properly. As more healthcare providers see the benefits of these techniques, the need for better anastomosis devices will continue to grow, improving patient outcomes and satisfaction.

  • Technological Advancements and Innovation in Device Design:

New technology and innovative designs are improving anastomosis devices. In 2024, new materials and techniques are making these devices more effective. For example, bioabsorbable materials, better suturing methods, and robotic-assisted surgeries are making it easier and safer for surgeons to connect tissues. Some devices now include smart features, like sensors that provide feedback during surgery. As companies continue to invest in research and development, the market for anastomosis devices will expand. These improvements will help address the unique needs of different types of surgeries and lead to better patient results.

  • Growing Prevalence of Chronic Diseases and Aging Population:

More people are developing chronic diseases, and the aging population is driving the need for anastomosis devices. As people age, they are more likely to develop health problems, like heart disease, cancer, or digestive issues, which often require surgery. In 2024, healthcare systems are facing more cases that need surgery, including those that require anastomosis. As chronic diseases become more common, healthcare providers are looking for better devices to help improve surgical results and reduce risks. This need is pushing manufacturers to create specialized anastomosis devices for specific health conditions, expanding the market.

We explore the factors driving the growth of the market, including technological advancements, consumer behaviors, and regulatory changes, along with emerging anastomosis devices market trends.

Leading Companies Operating in the Global Anastomosis Devices Industry:

  • Artivion Inc.
  • B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)
  • Becton, Dickinson and Company
  • Getinge AB
  • Intuitive Surgical Inc.
  • Johnson & Johnson
  • Meril Life Sciences Pvt. Ltd.
  • Peters Surgical
  • Synovis Micro Companies Alliance Inc. (Baxter International Inc.)

Anastomosis Devices Market Report Segmentation:

By Type:

  • Surgical Staplers
    • Manual
    • Powered
  • Surgical Sutures
    • Absorbable Sutures
      • Synthetic Sutures
      • Natural Sutures
    • Non-absorbable Sutures
      • Polypropylene
      • Nylon
      • Stainless Steel
      • Others
  • Automated Suturing Devices
    • Disposable
    • Reusable
  • Surgical Sealants and Adhesives
    • Natural/Biological
      • Fibrin-based
      • Collagen-based
      • Albumin-based
    • Synthetic and Semisynthetic
      • PEG Hydrogel-based
      • Cyanoacrylate-based
      • Others

By Application:

  • Gastrointestinal Surgeries
  • Cardiovascular and Thoracic Surgeries
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers and Clinics
  • Others

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Global Anastomosis Devices Market Trends:

The anastomosis devices market is expected to grow because of several important trends. In 2024, the trend towards personalized medicine means devices will be made to fit each patient's needs, improving surgical precision and results. The use of digital health technologies, like telemedicine and remote monitoring, will help doctors plan and care for patients better before and after surgery. Additionally, there is a push for more cost-effective solutions, such as single-use anastomosis devices, which help reduce the risk of infection. As awareness of the importance of training for surgical teams grows, manufacturers and healthcare providers will work more closely together, leading to better devices and improved care. These trends will continue to shape the market as the demand for better healthcare solutions rises.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
 Emailsa...@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145

 

 

Reply all
Reply to author
Forward
0 new messages